Search from the table of contents of 2.5 million books
Advanced Search (Beta)
Home > Annual Reports in Medicinal Chemistry > Chapter Four - Selective Inhibitors of PDE2, PDE9, and PDE10: Modulators of Activity of the Central Nervous System
Annual Reports in Medicinal Chemistry |
Manoj C. Desai
Academic Press
Annual Reports in Medicinal Chemistry
Chapter Four - Selective Inhibitors of PDE2, PDE9, and PDE10: Modulators of Activity of the Central Nervous System
Authors

Morten Jørgensen; Jan Kehler; Morten Langgård; Niels Svenstrup; Lena Tagmose

ARI Id

1665525371262_17124599

Access

Not Available Free

Pages

37-55

Table of Contents of Book
Showing 1 to 20 of 44 entries
Chapters/HeadingsAuthor(s)PagesInfo
Copyright
iv
Contributors
xv-xvi
Preface
Manoj C. Desai
xvii-xviii
Personal Essays
Chapter One - Challenges in Drug Discovery at Schering–Plough Research Institute: A Personal Reflection
A.K. Ganguly
3-14
Chapter Two - My Perspective on Time, Managers—and Scientific Fun
Christopher A. Lipinski
15-22
Chapter Three - A Career in Medicinal Chemistry—A Journey in Drug Discovery
Malcolm MacCoss
23-34
Section 1: Central Nervous System Diseases
Chapter Four - Selective Inhibitors of PDE2, PDE9, and PDE10: Modulators of Activity of the Central Nervous System
Morten Jørgensen; Jan Kehler; Morten Langgård; Niels Svenstrup; Lena Tagmose
37-55
Chapter Five - Beyond Secretases: Kinase Inhibitors for the Treatment of Alzheimer’s Disease
Federico Medda; Breland Smith; Vijay Gokhale; Arthur Y. Shaw; Travis Dunckley; Christopher Hulme
57-71
Chapter Six - Orexin Receptor Antagonists in Development for Insomnia and CNS Disorders
Scott D. Kuduk; Christopher J. Winrow; Paul J. Coleman
73-87
Section 2: Cardiovascular and Metabolic Diseases
Chapter Seven - Discovery and Development of Prolylcarboxypeptidase Inhibitors for Cardiometabolic Disorders
Sarah Chajkowski Scarry; John M. Rimoldi
91-103
Chapter Eight - Molecular Targeting of Imaging and Drug Delivery Probes in Atherosclerosis
Cesare Casagrande; Daniela Arosio; Claudia Kusmic; Leonardo Manzoni; Luca Menichetti; Antonio L’Abbate
105-118
Chapter Nine - Oral GLP-1 Modulators for the Treatment of Diabetes
David J. Edmonds; David A. Price
119-130
Section 3: Inflammation Pulmonary GI Diseases
Chapter Ten - Recent Advances in the Discovery and Development of CCR1 Antagonists
Penglie Zhang; Daniel J. Dairaghi; Juan C. Jaen; Jay P. Powers
133-147
Chapter Eleven - Emerging Targets for the Treatment of Idiopathic Pulmonary Fibrosis
Matthew C. Lucas; David C. Budd
149-167
Chapter Twelve - Targeting the Nuclear Hormone Receptor RORγt for the Treatment of Autoimmune and Inflammatory Disorders
T. G. Murali Dhar; Qihong Zhao; David W. Markby
169-182
Section 4: Oncology
Chapters/HeadingsAuthor(s)PagesInfo
Showing 1 to 20 of 44 entries
Similar Books
Similar Chapters
Similar Thesis

Similar News

Similar Articles
Similar Article Headings